Jump to content

2,5-Dimethoxy-4-isopropylamphetamine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
SwisterTwister (talk | contribs)
Nothing blatant here
Line 1: Line 1:
{{csb-pageincludes|1=http://www.lycaeum.org/wiki/2,5-Dimethoxy-4-propylamphetamine}}

{{Drugbox
{{Drugbox
| IUPAC_name = 1-(2,5-Dimethoxy-4-isopropyl-phenyl)propan-2-amine
| IUPAC_name = 1-(2,5-Dimethoxy-4-isopropyl-phenyl)propan-2-amine

Revision as of 02:19, 4 July 2015

2,5-Dimethoxy-4-isopropylamphetamine
Identifiers
  • 1-(2,5-Dimethoxy-4-isopropyl-phenyl)propan-2-amine
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H23NO2
Molar mass237.34 g/mol g·mol−1
  • InChI=1S/C14H23NO2/c1-9(2)12-8-13(16-4)11(6-10(3)15)7-14(12)17-5/h7-10H,6,15H2,1-5H3
  • Key:UEEAUFJYLUJWQJ-UHFFFAOYAM

2,5-Dimethoxy-4-isopropylamphetamine (also known as DOiP and DOiPR) is a psychedelic drug of the phenethylamine and amphetamine chemical classes.[1][2][3] It was first synthesized by Alexander Shulgin, and was described in his book PiHKAL (Phenethylamines i Have Known And Loved). Shulgin described DOiPR as being at least an order of magnitude weaker than DOPr, with doses of 20-30mg required to produce valid changes in mental state.[4] Very little data exists about the pharmacological properties, metabolism, and toxicity of DOiPR.

See also

References

  1. ^ Richard A. Glennon, Mark R. Seggel (1989). "Interaction of phenylisopropylamines with central 5-HT2 receptors. Analysis by quantitative structure-activity relationships". ACS Symposium Series. 413: 264–280. doi:10.1021/bk-1989-0413.ch018. {{cite journal}}: Unknown parameter |month= ignored (help)
  2. ^ Mark R. Seggel, M. Y. Yousif, Robert A. Lyon, Milt Titeler, Bryan L. Roth, Eva A. Suba, Richard A. Glennon (1990). "A structure-affinity study of the binding of 4-substituted analogs of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors". Journal of Medicinal Chemistry. 33 (3): 1032–1036. doi:10.1021/jm00165a023. PMID 2308135. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  3. ^ F. A. B. Aldous, B. C. Barrass, K. Brewster, D. A. Buxton, D. M. Green, R. M. Pinder, P. Rich, M. Skeels, K. J. Tutt (1974). "Structure-activity relations in psychotomimetic phenylalkylamines". Journal of Medicinal Chemistry. 17 (10): 1100–1111. doi:10.1021/jm00256a016. PMID 4418757. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  4. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). "PiHKAL: A Chemical Love Story #71 DOPR". Transform Press. p. 978. Retrieved 27 June 2015.{{cite web}}: CS1 maint: multiple names: authors list (link)